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EXECUTIVE SUMMARY
Emergency contraception (EC) is an innovation that empowers women to avoid pregnancy
following unprotected intercourse. It differs from other conventional methods of family planning in
that the intervention occurs after exposure to unprotected intercourse. It is, therefore, appropriate
in situations where either no contraceptive method was used, a regular method was missed,
contraceptive failure occurred as in condom breakage, or in cases of rape and sexual assault.
Appropriate and widespread use of EC can eliminate most cases of unwanted pregnancy and its
sequelae such as unsafe abortion and associated maternal morbidity and mortality. Despite the
huge potential in EC, its utilization has not been taken to scale in many developing countries,
including Nigeria where 11 percent of all births by women aged 15-49 are either unwanted or
mistimed, and unmet need for family planning among currently married women is as high as 20.2
percent (NPC and ICF Macro, 2009). Lack of proper knowledge and understanding of EC among
service providers in Nigeria as well as insufficient policy support are contributory to its poor
uptake.
In order to create a supportive policy and service delivery environment for EC and improve uptake,
the Population Council, in 2011, conducted in Nigeria a survey of service providers' knowledge,
attitudes and practices regarding EC, supplemented by indepth interviews with 'Key Opinion
Leaders' (KOLs) regarding their perceptions. This study revealed gaps that have implications for
policy and programming (Ahonsi, et al, 2012). In collaboration with the International Consortium
for Emergency Contraception (ICEC), the Council convened a ‘Day of Dialogue’ on EC to discuss the
key research findings and to recommend strategic considerations for repositioning EC within the
country's family planning program. The event drew participants from both the public and private
sectors, local and international non-governmental organizations, regulatory bodies and donor
agencies, United Nations agencies and advocacy organizations. The dialogue yielded broad
consensus on a number of critical policy and program/service delivery issues around expansion of
access to EC:
·

Ensure that the commonly available EC brands in the country such as Postinor-2 and
Pregnon are included on Nigeria's Essential Drugs List (EDL);

·

Pro-actively deploy family planning community champions to make a case for the
expansion of access to EC for all categories of women, following the example of other
successful public health initiatives such as the Polio Eradication Initiative (PEI);

·

Conduct intensive advocacy using scientific evidence to clear up prevailing
misconceptions about EC in Nigeria;
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·

Devise means to provide accurate information to service providers, potential clients and
policy-makers in highly accessible and culturally-sensitive ways in order to minimize
resistance and improve uptake; and

·

Leverage opportunities to disseminate current research findings on EC at meetings and
conferences of professional bodies such as the Nigeria Medical Association and the
Association of Patent Medicine Vendors.
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INTRODUCTION
Emergency contraceptives (ECs) are relatively new innovations in Nigeria's family planning (FP)
strategy. With maternal mortality currently at 545 per 100,000, a modern contraceptive
prevalence rate of 10 percent, and with over one-third of Nigeria's 170 million population aged 1024, there are sufficient reasons to undertake efforts to address the health outlook among the
rapidly growing adolescent population. Current evidence suggests that induced abortion, as a
result of unwanted pregnancy, accounts for 11 percent of maternal mortality in Nigeria, indicating
a high unmet need for contraception, including emergency contraception. Indeed, 11 percent of
all births to women of reproductive age in Nigeria are either unwanted or mistimed, and 20.2
percent of currently married women have unmet need for family planning methods to stop or delay
childbearing (NPC and ICF Macro, 2009).
Emergency contraceptive pills (ECPs) are highly effective in preventing unwanted pregnancy and
are suitable for both married and unmarried women who after unprotected sex wish to avoid
pregnancy. In spite of the mounting evidence that ECs are very effective and safe, they are not
widely available for use among the vulnerable groups for reasons such as fears about safety and
future infertility and concerns that EC is an abortifacient.
Postinor 10 was the first EC that entered the Nigerian market in the late 1990s, before it was
replaced by Postinor 2 on the recommendation of the World Health Organization (WHO) in 2001.
These were the only registered ECs in Nigeria until 2007 when the Society for Family Health (SFH)
started distribution of Pregnon, a subsidized brand, to expand options to all classes of Nigerians
who need EC. Between 1999 and 2013 the uptake of ECPs has grown from 160,000 to at least
2,000,000 doses per annum despite lack of full public sector engagement. At present, uptake of
ECP is less than 1% (Ahonsi, et al, 2012). There is an absence of full government participation in EC
provision, with distribution almost entirely under the control of the largely unregulated private
sector. This skewed supply situation is unfavorable for healthy institutionalization of this essential
commodity into the country's FP program.
In order to improve the program and policy environment for EC in Nigeria, the Population Council,
with funding from the Bill and Melinda Gates Foundation, and through the International
Consortium for Emergency Contraception (ICEC) conducted a study in 2011 to document
providers' knowledge, attitudes, beliefs and practices regarding EC and to identify key opinion
leaders' (KOLs) perspectives and insights pertaining to EC policy and program issues. The findings
from this study are described in more detail in a Council-published Research Brief (Ahonsi, et al,
2012). It documents several interesting program and policy-related issues that can be used to
guide policies and programs.
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To maximize the utilization of the findings from this study for the improvement of the EC policy and
service environment in Nigeria, the Council, in collaboration with the ICEC convened a 'Day of
Dialogue' that brought together a broad range of stakeholders from government ministries and
agencies, local and international non-governmental organizations, including UNFPA, Nigerian
Urban Reproductive Health Initiative, the Patent Medicine Vendors Association, Pathfinder
International, Advocacy Nigeria, Education As a Vaccine (a youth-serving NGO), the Family
Planning Action Group, and representatives of Society for Family Health (SFH, the single largest
supplier of EC to the Nigerian market), Liverpool School of Tropical Medicine, and Association for
Reproductive and Family Health. This report presents the highlights of this dialogue.

A cross-section of the participants
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ADDRESSING PREVAILING MISCONCEPTIONS
Participants reviewed several important misconceptions identified by the Population Council
research regarding EC, such as: EC increases the risk of pregnancy; EC increases promiscuity
among users; EC promotes contraceptive risk-taking behaviors; EC decreases use of condom and
other methods of birth control and, invariably, increases the risk of transmission of STIs; EC is an
abortifacient, and EC is not as protective as being advocated. Indeed, a youth advocate and mentor
testified that many young girls affiliated to her organization still prefer harsh unproven traditional
methods of avoiding a pregnancy such as salt solution, potash, and alum to EC. Further
complicating these misconceptions is the availability in the market of counterfeit EC products and
other family planning (FP) methods. While some of these methods are not ECs in the first place, the
existence of counterfeit commodities affects EC uptake as well.

To support the demystification of EC and promote accurate information, participants agreed upon
the following content for key messages to policy makers, program managers and clients:
ECPs are safe: Participants agreed that ECPs are indeed safe and, as the longitudinal study of
Levonorgestrel has confirmed, they are well-tolerated and tend to leave the body quickly, thus
dispelling the long-held misperception that EC increases vulnerability to addiction, toxicity, ectopic
pregnancy, increased cancer risks and infertility.
EC is not an abortifacient: Another interesting point of agreement among participants was that EC
should be set aside from the category of abortificient drugs, in that EC (whether ECPs or an IUD
insertion after unprotected sex) is adopted by women immediately and only within five days after
unprotected sex when pregnancy is unlikely to be established, and abortion out of the question. In
other words, it is taken before fertilization occurs, which effectively eliminates the chances of
associating it with abortion.
Legality of ECPs: Consensus was also reached at the dialogue that ECPs are legal in Nigeria
although they are not yet included on the country's Essential Drugs List (EDL). There was a clarion
call from the forum to hasten the incorporation of EC on the EDL to enable appropriate public
budgetary provision for its purchase and distribution. More importantly, the dialogue recognized
the potential in EC to offer women a second chance to prevent pregnancy when a regular method
fails (e.g. condom breaks), they inadvertently skip their daily contraceptive pills, no method is used,
or when exposed to sexual violence. Participants committed to integrating this vital information in
routine family planning messages in the country.
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STIMULATING DEMAND AND UPTAKE
The forum then explored strategies on how to create demand and stimulate uptake in order to
increase use of EC beyond the current estimated level of 2 million doses per annum. Participants
identified several factors responsible for the initial expansion to this current level, namely: the
massive launch of ECs by social marketers to generate awareness for providers and users in major
Nigerian cities; the training of public and private sector providers to increase their understanding
of the use of the product and to eliminate misconceptions; targeted promotion around critical
user-groups, such as girls in tertiary institutions; leveraging existing family planning (FP) and
reproductive health (RH) programs to drive EC access and availability; use of private sector
pharmaceutical distribution outlets; and, promoting sustainability through the adoption of an
innovative cost recovery strategy and the provision of Pregnon, a subsidized brand that expanded
consumer options.

It was unanimously agreed that 2 million doses of EC pills
per annum is far below what is needed for a country with a
teenage population of around 60 million.

To build on these early lessons and strategies, the forum called for renewed efforts to expand EC
demand and uptake through the following measures:
Over-the-counter purchase: The forum was unanimous regarding the safety and appropriate
provision of ECPs for over-the-counter (OTC) purchase and use by teenagers and older women
without monitoring from a health provider. OTC access is critical because ECPs are more effective
the sooner they are administered following exposure. A requirement for a prescription entails two
trips: first to a clinic to get the prescription and second, to a pharmacist. This creates unnecessary
obstacles and significantly impinges on the 'safety window.' This is the case even more so in rural
dwellings that lack clinics and/or access to prompt transport services.
Service provider updates: Participants further observed that service providers are critical to
improvement in uptake of ECs and need to be continuously trained using innovative strategies and
materials, such as the Patent Medicine Vendors' (PMVs) Training Manual developed by SFH, which
is regularly updated. The contents of the manual, which include FP counseling and referrals was
developed under a public-private partnership. Part of the training approach, as suggested by the
forum, should include leveraging concurrent meetings and conferences of relevant professional
bodies to present current information on best practices around EC, because they are important
messengers of this information to users.
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Interpersonal communication agents' orientation:

The majority of participants proposed

orientation and counseling training for Inter-Personal Communication (IPC) Agents, as one way to
spread accurate information about EC. Interpersonal communication agents in rural areas are
often beyond the reach of contemporary advocacy efforts. Using a dedicated team of pharmacists
to undertake one-on-one training of providers on EC nationwide and creating sales teams to
complement these efforts would further make current knowledge of EC available to both providers
and clients in difficult and hard-to-reach locations. There remains a great need for dissemination of
accurate and culturally appropriate information on EC to clients especially young women.

“Time should be spent to give information to the clients because it is the
information you give to the people at the community that makes the difference.
When young people get the right information, not necessarily about abortion, they
will be able to share it among themselves. This is what should be considered very
important to us” – Youth Peer Health Educator
EC in private sector outlets: Participants proposed boosting availability of EC in outlets similar to
those being used to distribute condoms, supporting a key role for the private sector, in addition to
the current public-private partnership.
Total market approach: The UNFPA representative affirmed that EC is one of the 13 life-saving
commodities contained in the UN Commission Report. UNFPA traditionally supports the public
sector in the procurement of family planning commodities but believes that ECs can be made more
widely available by taking a total market approach requiring collaboration between the public and
private sectors. Since the 2013 NDHS is underway and is expected to provide more insights on
where women obtain contraceptives, including EC, it would help to inform where best to
concentrate access expansion efforts – public or private sector.
Assuring product quality: The issue regarding the quality of EC products has negatively affected
and will continue to impact uptake. Therefore, additional efforts are required to procure ECs from
the right sources since FP failure is an issue that touches on the lives of many women. Women who
have found themselves with fake or substandard EC have been known to become more fatalistic
about their chances of preventing unwanted pregnancy.
“As a community of practitioners, we need
to understand the anxiety of a woman who
envisages that she might get pregnant as
a result of unprotected sexual intercourse”
- National NGO Program Manager
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An innovative strategy to support quality assurance is SFH's roll-out of a mobile-phone
authentication service with Postinor-2. Under the mobile phone authentication service scheme,
when prospective users buy the product, they send an SMS, free of charge, to a particular number
and receive confirmation about whether the product they are buying is the fake or authentic.
Nonetheless, the forum stressed that since the private sector may not reach as many Nigerians
with modern health services as the public sector, both sectors have to work together to expand
access to EC for needy girls and women.

“We have all agreed here that most family
planning needs are being catered for through the
private sector because of the inadequacies of the
public sector. For example, undue time-wasting in
public sector may not be tolerated by a woman in
medical emergency. so many would resort to care
in private facilities. Therefore, the empowerment
of the private sector for effective service delivery
is a right step in the right direction” – NURHI
representative

Strengthening the supply chain: Participants raised another important issue associated with
stimulating higher EC uptake, namely, strengthening the supply chain for delivering ECs to the
market. While actors in the public sector indicated willingness to undertake product procurement
and distribution through its regular channels, private sector stakeholders equally underscored the
need to use their established channels. In the final analysis, it was agreed that both channels
could be effectively combined for greater outcome.
Increasing access to EC among rape victims: Participants also addressed the issue of EC use to
protect rape victims against unwanted pregnancies. It was advocated that since rape victims' first
port of call is sometimes the police station, they should have immediate access to ECPs at the
police stations even before statements are obtained from them. In the rural areas, there may be a
primary health care (PHC) center that could supply ECs to the station and monitor their use. Police
stations should be willing to dispense the drug to rape victims since it does not cost them anything
to do so; however training is needed, preferably for designated female police officers, on
dispensing the drug and offering complementary counseling before investigating police officers
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take the necessary records and follow up. Basically, ECs can be administered at a cost that is
affordable, if not free. Similarly, the same strategy could be applied to gas stations across the
country, which could immensely boost EC products distribution, availability, monitoring, evaluation
and reporting. Police involvement in dispensing ECs to rape victims can only be realized through
policy change on the part of the Nigeria Police Force.

“I think that we have to take part of the advocacy to the police and
complement it with public awareness creation, so that officers-incharge can be capacitated to also offer counseling and make the
service available. This can be used as part of the broad strategy of
mainstreaming gender and HIV/AIDS advocacy in the police service
and establishing gender desks in police stations” – Advocacy Nigeria
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SCALE UP APPROACHES
Factors affecting the scale up of EC were extensively explored by participants. They described EC
as a 'low hanging fruit' that is difficult to pluck considering all the misperceptions and valueclarification issues still associated with them, especially among providers in the public sector. In
Nigeria, scale-up is also being slowed down by a combination of factors such as inadequate public
sector involvement in EC supply, large number of providers yet to be trained on eligibility criteria for
EC, high transfer/attrition rates of trained providers and the high cost of EC products in the face of
high level of poverty especially in the northern regions of the country.
To address scale up, the following approaches were discussed by participants:
Ensure provider training includes values clarification: Providers often do not request ECPs even
when they are ordinarily available, and given the misperceptions that many have around EC, this
issue has to be tackled through targeted sensitization and training. Indeed, values clarification
around EC (and FP in general) among SRH/FP program managers and service providers
repeatedly came up as key to EC expansion in Nigeria.

“We have heard of a Family Planning Coordinator
who buries FP commodities and key health
personnel who hide FP products in their toilets” –
INGO Senior Manager

Continue to engage the private sector: In order to achieve rapid scale-up, participants felt it may
be necessary to work closely with the private sector because of its flexibility in operation. For
instance, providers in the private sector work over the weekends and for much longer hours on
weekdays. Accordingly, there is need to train and support them with the necessary materials and
create community level awareness about EC.Another point of consensus was that there is always
paucity of funds, and so scale-up may be difficult to achieve considering that the private sector
relies on donor funding that is fast-shrinking, unlike the government that can make policies and
back it up with funds. Therefore, private sector operators must think out of the box for funding
strategies that will ensure the sustainability of product delivery at whatever level they operate.
Integrate EC into existing FP/RH portfolios: The forum noted that it will be of tremendous help to
integrate EC into the FP or RH portfolios being implemented by various organizations rather than
treating it as a stand-alone or special topic. Apart from accomplishing the common broad goal of
preventing unwanted pregnancy, integrating EC into existing FP/RH information and service
delivery platforms and channels will be more cost-effective and yield programme synergies. It
should, therefore, not be separated from the routine services, and if it is not available at any clinic,
there should be referrals to where it is available. There needs to be specific promotion (across and
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by all FP/SRH programs) of the notion that if a woman has unprotected sex, she can still avail
herself of EC to prevent unwanted pregnancy. Such a messaging push will be quite timely now that
Nigeria appears to be seriously looking at expanding youth-friendly RH services, and more donor
agencies are re-visiting the issue of youth-friendly services. The country needs to be strategic about
ensuring that EC is not put aside but is part of the comprehensive FP messaging and services
especially when it comes to youth-friendly RH programs.
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STRENGTHENING POLICY SUPPORT
The participants agreed that an enabling policy environment is thus needed to give momentum to
expansion of EC uptake in Nigeria and proposed the following:
Expand the dialogue to all levels of government: The need to expand discussion of the policy
environment beyond the role of the federal government (FG) was strongly recommended given that
health policy-making and translation occurs across the three (3) tiers of government –
federal/national, state and local. It is also essential to consider the means to increase legislative
support since the EC study revealed lack of proper knowledge and information around EC issues
amongst both legislators and public sector officials.
In view of the foregoing, an important part of creating a suitable policy environment for EC is to
ensure disseminated information is accessible and digestible to key policy actors and decisionmakers across the three tiers of government and the legislative, judicial and executive arms. This
information needs to get to them in a way that they can understand and easily act upon given how
very busy and crowded their agendas are.
Involve professional organizations: In addition, professional groups such as the Nigeria Medical
Association (NMA), Pharmaceutical Society of Nigeria (PSN) and the Society of Obstetricians and
Gynecologists of Nigeria (SOGON) and others, who can serve as either facilitators or stumbling
blocks, should be engaged because they are also policymakers and influencers in their own right.
For instance, recently in Ibadan, the PSN went about closing down shops that were selling ECPs,
particularly Postinor 2, on the erroneous assumption that PMVs are not authorized to dispense EC
pills. They obviously did not understand nor realize that Postinor 2 has now been upgraded to an
over-the-counter (OTC) drug.
ECs on the Essential Drugs List: A major policy action repeatedly put on the table was how to build
on the value of the existing training manuals and protocols on EC by getting the product listed on
the Essential Drugs List (EDL) in Nigeria. Enabling laws are required at each specific level of policy
to address the obvious issue of including ECs in the EDL. This should go hand-in-hand with the
effort to materialize the new monetary pledge (additional $8.35 million per year over 2013-2016)
for expansion of access to FP in Nigeria by the President of Nigeria at the July 2012 London Summit
on FP. There is the need to use available manuals to train providers and government officials at
every level around FP/RH, and ECPs need to be central to these efforts.
Product quality assurance: Quality assurance and elimination of fake drugs is a major policy
issue that the National Agency for Foods, Drugs Administration and Control (NAFDAC) has already
initiated and working intensely to achieve. But attention was frequently called at the forum to the
fact there are several fake EC pills on the Nigerian market which implies that actual demand for
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ECPs is far higher than the 2 million that SFH currently distributes annually. Though so many cases
of counterfeit products have been reported to NAFDAC, the situation remains quite worrisome.
Participants recommended continued and intensive advocacy with NAFDAC to improve the
situation.
Engage local governments: Another forward-moving step noted by the forum would be for local
governments to be empowered to rise up to their responsibilities of managing the PHCs under
their jurisdiction, to have RH budget lines in their annual budgets and to train their health care
personnel on RH - and EC - related issues. At present, they are not aware of the role of ECs and what
they can do to support increased access; therefore, intensive advocacy is required.
Adolescents: On how best to speedily address the EC needs of adolescents, a widely expressed
view was that since EC is captured in the National Family Planning Service Curriculum, ensuring
that the product is included in Nigeria's EDL, and designated as a product that must be part of the
services offered by a clinic to be considered youth-friendly is imperative. The forum, therefore,
strongly urged participants from the Federal Ministry of Health to fully take this on board as part of
the ministry's ongoing effort to develop the national minimum standard for youth-friendly RH
services.
Brand marketing: It was also of great interest when participants learned that the subsidized EC
product, Pregnon, is not as fast-selling as the more expensive product, Postinor-2, implying that
affordability and brand loyalty were germane to EC uptake. Clearly, people are used to Postinor 2
and are ready to pay a premium to get that trusted medicine. It also underscores the value of
promoting a unique and dedicated product that is protected against counterfeiting.
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NEXT STEPS
An immediate goal will be to ensure that ECPs such as Postinor-2 and Pregnon are included on
Nigeria's EDL. Using this 'Day of Dialogue' as a momentum-gathering event, stakeholders
promised to join forces together in pursuing this goal. Participants suggested borrowing a page
from the ongoing national polio eradication effort which uses champions in communities or
organizations to drive the cause in their respective settings, rural and urban. Empowering the
champions of existing FP programs with sufficient EC knowledge will be of immense help,
especially when they are counseling clients on methods and trying to help communities to take
actions on major FP/RH issues.
There is strong and compelling scientific evidence about the safety of ECPs which can firmly
counter prevailing misperceptions associated with it. Therefore, there is a need to urgently tackle
these misconceptions by working to understand and resolve the reasons for resistance against EC
uptake. It is also pertinent to understand why potential clients are not offered EC as an option and
the reasons behind portraying EC as abortificient and for associating it with the promotion of
promiscuity in women, so that strategies can better address these problems.
Equally of immense importance is the need to find a way to more effectively disseminate
information on EC and other RH issues. To achieve this requires the simplification of the
information and making it easily available to the larger public through massive and persistent
advocacy and sensitization.

“People already know enough about HIV, how it is
acquired, how it leads to AIDS and how it is managed.
But we have not been able to achieve such high level
of knowledge and awareness around FP” – Head of an
INGO

At every meeting, people still raise a lot of questions regarding FP (including EC) that ought to have
been long settled. The growing donor attention to FP provides a new opportunity for the FP/RH field
in Nigeria to make the kind of positive impact that the HIV/AIDS field has been able to achieve.
What is immediately required is for the FP/RH community of practice to sustain and increase its
community mobilization, public education, service delivery and policy advocacy efforts for the
expansion of access to FP, including EC, for all categories of women in Nigeria.
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Conclusion
This 'dialogue' is the first of its kind around emergency contraception in Nigeria. It brought
participants from diverse backgrounds, and presented the current information on emergency
contraception from the perspectives of the service providers and policy-makers, and thus, set the
stage for a constructive discourse. Various commitments were made ranging from building and
sustaining advocacy efforts, increasing collaboration among relevant partners, mentoring and
capacity building for service providers, and improved monitoring of program/service delivery.
However, this new-found commitment for EC will require regular and on-going meetings,
information sharing and collaborative actions in the months and years ahead if the set
commitments are to be fulfilled.
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APPENDIX I
The Agenda for the ‘Day of Dialogue’

Day Of Dialogue: Expanding opportunities for increased access
to emergency contraception (EC) in Nigeria

16

APPENDIX II
List of participants
Jennifer Anyanti
Director, Technical Services
Society for Family Health, Abuja
Email: janyanti@sfhnigeria.org

Sylvia Ekponimo
Team Leader
Education as A Vaccine, Abuja
Email: sylviae@evanigeria.org

Obinna Nwogu
Fund Manager
Society for Family Health, Abuja
Email: onwogu@sfhnigeria.org

Charity Ibeawuchi
Advocacy Advisor
Nigerian Urban Reproductive Health
Initiative, Abuja
Email: cibeawuchi@nurhi.org

Augustina O. Salami
Program Coordinator
Education as A Vaccine, Abuja
Email: tina.saami@gmail.com
Oyemina Rita
Vice President
Nigeria Association of Patent and
Proprietary Medicine Dealers, Abuja
Sa'adatu Sule
Technical Advisor for Nigeria,
Making It Happen Programme
Liverpool School of Tropical Medicine
Email: saasule@yahoo.com
O. Ladipo
President /Chief Executive Officer
Association for Reproductive and
Family Health, Abuja
Email: oaladipo@yahoo.co.uk
Hajiya Bilkisu Yusuf
Executive Director
Advocacy Nigeria/Family Planning
Action Group, Abuja
Email: bilkisuy@yahoo.com

17

Celina Johnson
Public-Private Sector Advisor
Nigerian Urban Reproductive Health
Initiative, Abuja
Email: cjohnson@nurhi.org
Wale Adedeji
Chief Operating Officer
Society for Family Health, Abuja
Email: wadedeji@sfhnigeria.org
Tali G. Butkap
Deputy Director
Public Health and Human Services
Secretariat
Federal Capital Territory, Abuja
Email: Drtali2001@yahoo.com
Kehinde Oshinowo
Director, Programs
Association for Reproductive and
Family Health, Abuja
Email: Kosmowo2@yahoo.com

Farouk Jega
Country Representative
Pathfinder International Nigeria
Abuja
Email: fjega@pathfinder.org

Cynthia Mmaduka
Monitoring and Evaluation Officer
Education as A Vaccine
Abuja
Email: Cynthiaonyekaeli30@yahoo.com

Bose Adeniran
Head of Reproductive Health Division
Federal Ministry of Health, Abuja
Email: boseade4000@yahoo.com

Obi Oluigbo
Chief Technical Officer
Society for Family Health Abuja
Email: ooluigbo@sfhnigeria.org

MEETING REPORT

Mariam Momoh
Family Planning Coordinator
Federal Capital Territory, Abuja
Email: tomimariam@yahoo.com

Godwin Unumeri
Consultant Centre for Citizens with
Disabilities Lagos
Email: unumerig@yahoo.com

Olanike Adedeji
National Program Officer
Reproductive Health Commodity Supply
United Nations Population Fund, Abuja
Email: oadedeji@unfpa.org

Joel Odoh
President
Nigeria Association of Patent and
Proprietary Medicine Dealers, Abuja

Nasa Eke
Fund Raiser
Education as A Vaccine
Email: leonaeke@gmail.com

Odoh Theophilus
Secretary General
Nigeria Association of Patent and
Proprietary Medicine Dealers, Abuja
Akinkunmi Agnes
Program Officer
Federal Ministry of Health
Abuja
Email:Yemisiakinkunmi2000@yahoo.com

Orji Ejike
Country Director
IPAS- Nigeria
Abuja
Email: dreoji@yahoo.com
Sarah Rich
International Consortium for Emergency
Contraception, New York
Email: srich@familycareintl.org
Babatunde Ahonsi
Country Director
Population Council, Abuja.
Email: bahonsi@popcouncil.org
Salisu Ishaku
Senior Program Manager
Reproductive Health
Population Council, Abuja.
Email: sishaku@popcouncil.org
Gloria Adoyi
Program Officer
Reproductive Health
Population Council, Abuja.
Email: gadoyi@popcouncil.org

Wophill Rotmwa
Program Officer, Advocacy, Policies and
Campaign
Education as A Vaccine
Email: Rotwop286@gmail.com
Temitope Bombata
Chief Nursing Officer
Federal Ministry of Health
Abuja
Email: Taboms1963@yahoo.com
Abdulmalik Abdulazeez
Program Officer
Education as A Vaccine, Abuja
Email: bushgame2003@yahoo.com
Erega Bangha
Monitoring and Evaluation Officer
Public Health Department
Federal Capital AIDS & STIs Control
Program
Abuja
Email:erecaly@yahoo.com

Day Of Dialogue: Expanding opportunities for increased access
to emergency contraception (EC) in Nigeria

18

REFERENCES

1. Ahonsi B, Ishaku S, Araoyinbo I, and Oginni A, (2012), Providers' and Key Opinion
Leaders' Attitudes, Beliefs, and Practices Regarding Emergency Contraception in Nigeria:
Key Findings, Program Brief, New York, Population Council.
2. Brady M. and McGrory E. (2007), Insights and Evidence from Product Introduction:
Lessons for Microbicides, Day of Dialogue Series, New York, Population Council.
3. National Population Commission (NPC) and ICF Macro (2009) Nigeria Demographic
and Health Survey 2008. Abuja, Nigeria: NPC and ICF Macro.

19

MEETING REPORT

Day Of Dialogue: Expanding opportunities for increased access
to emergency contraception (EC) in Nigeria

20

Nigeria
16 Mafemi Crescent
Off Solomon Lar Way
Utako District
Abuja
www.popcouncil.org

